InPen App, Model/CFN Number: MMT-8061 (Android Users)

FDA Recall #Z-0958-2026 — Class II — November 13, 2025

Recall #Z-0958-2026 Date: November 13, 2025 Classification: Class II Status: Ongoing

Product Description

InPen App, Model/CFN Number: MMT-8061 (Android Users)

Reason for Recall

When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia.

Recalling Firm

Medtronic MiniMed, Inc. — Northridge, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

8251

Distribution

US: IL, AZ, MN, NE, KS, TN, CA, FL, TX, WA, MO, NC, NY, WI, IN, ME, CT, RI, MD, PA, OK, KY, MA, DE, UT, ID, VA, MI, OH, LA, NJ, IA, MT, HI, AR, OR, SC, AL, CO, WY, VT, NV, GA, MS, SD, AK, WV, NH, ND, NM. OUS: Austria, Belgium, Chile, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden, Switzerland, United Kingdom

Code Information

Software Versions: 7.5.0, 7.5.1, and 8.0.0. UDI-DI: 00763000974596

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated